argenx (Euronext & Nasdaq: ARGX) has commenced a tender offer to acquire all outstanding shares of Forte Biosciences, Inc. (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE